Loading provider…
Loading provider…
Hematology & Oncology Physician in Beverly Hills, CA
NPI: 1437375128Primary Employer
Valkyrie Global
valkyrieglobal.ca
HQ Phone
Get MD, PHD, MPH David's Phone Numberphone_androidMobile
Get MD, PHD, MPH David's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
2011 - 2025
LA State Medical License
2012 - 2015
RI State Medical License
2005 - 2007
CA State Medical License

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
Rhode Island Hospital/Brown University Health
Fellowship • Hematology and Medical Oncology
2005 - 2008
Norwalk Hospital/Yale University
Residency • Internal Medicine
2002 - 2005
Humboldt University of Berlin - Charite Faculty of Medicine
Medical School
Until 1999
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 137 | 469 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 108 | 242 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 102 | 102 |
| 4 | J7030Infusion, normal saline solution , 1000 cc | 56 | 175 |
| 5 | 96372Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 47 | 173 |
Authors: Song, Byeongdo, Kim, Jung Kwon, Lee, Hakmin, Lee, Sangchul, Hong, Sung Kyu, Byun, Seok-Soo, Oh, Jong Jin
Journal: World J Urol
Publication Date: 2024-04-09
Marrow cell genetic phenotype change induced by human lung cancer cells.
Authors: Peter Quesenberry, Bharat Ramratnam, Gerald Colvin, John Reagan, Jason Aliotta
Publication Date: 2009-05
Lead Sponsor: G1 Therapeutics, Inc.
Intervention / Treatment: DRUG: Trilaciclib, DRUG: Sacituzumab Govitecan-hziy
Lead Sponsor: Inhibrx Biosciences, Inc
Intervention / Treatment: DRUG: Carboplatin, DRUG: Temozolomide, DRUG: Cisplatin, DRUG: Pemetrexed, DRUG: Irinotecan, DRUG: 5-fluorouracil, DRUG: INBRX-109
Lead Sponsor: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: Placebo, DRUG: Canakinumab